Evercore Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EVR research report →
Range $315 – $575
Price Chart
About the company
Evercore Inc. functions as an autonomous investment banking advisory firm, maintaining a substantial international presence with operations spanning the United States, Europe, and Latin America. The company is structured into two core business units: Investment Banking and Investment Management.
- CEO
- John S. Weinberg
- IPO
- 2006
- Employees
- 2,835
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on EVR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $10.32B
- P/E
- 13.83
- Fwd P/E
- 13.65
- PEG
- 0.32
- P/S
- 2.12
- P/B
- 5.36
- EV/EBITDA
- 9.37
- Div Yield
- 1.27%
- Gross Margin
- 98.61%
- Op Margin
- 22.20%
- Net Margin
- 15.62%
- ROE
- 39.99%
- ROIC
- 23.18%
Latest fiscal year · YoY change
- Revenue
- $3.88B+29.5%
- Gross Profit
- $3.86B+29.4%
- Op Income
- $793.81M
- Net Income
- $591.92M+56.5%
- EPS
- $15.29+55.1%
- OCF Growth
- +27.2%
- FCF Growth
- +23.4%
- 52W High
- $388.71
- 52W Low
- $245.47
- 50D MA
- $272.92
- 200D MA
- $311.07
- Beta
- 1.46
- RSI (14)
- 42
- Avg Volume
- 523.15K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Evercore posted record third-quarter results on broad-based strength across advisory, capital markets, and related businesses, while management said record backlogs and healthy client engagement support continued momentum.· October 28, 2026
- Adjusted net revenues were nearly $1.2 billion, up 13% year over year and the sixth straight quarterly revenue record.
- Adjusted diluted EPS was $4.28, up 23% year over year; GAAP EPS was $3.93.
- Advisory fees hit a record $1 billion, with underwriting revenue up 27% to $56 million; commissions were $61 million, down 4%.
- The adjusted compensation ratio improved to 63% and the adjusted non-comp ratio fell to 14.1%; year to date non-comp ratio was 13.7%.
- Management said backlog is at record levels, sponsor activity is improving, and non-M&A businesses remained strong across restructuring, ECM, debt advisory, PCA, and wealth management.
Third-quarter 2026 GAAP net revenues were $1.2 billion, operating income was $243 million, and GAAP EPS was $3.93. Adjusted third-quarter net revenues were nearly $1.2 billion, up 13% year over year; adjusted operating income was $270 million, up 18%; and adjusted EPS was $4.28, up 23%. Record adjusted advisory fees were $1 billion, up 14%; underwriting revenue was $56 million, up 27%; commissions and related revenue were $61 million, down 4%; and adjusted asset management and administration fees were $26 million, up 9%. The adjusted compensation ratio was 63%, down 200 basis points year over year, and adjusted non-comp expenses were $166 million, with a 14.1% non-comp ratio. Cash and investment securities were approximately $2.8 billion at September 30, up from $2.4 billion a year ago. Evercore returned $189 million to shareholders in the quarter and over $1 billion through the first nine months. Management did not give formal quarterly or full-year financial guidance, but said activity levels should remain strong, backlog is at record levels, and activity is expected to remain healthy into next year.
John Weinberg framed the quarter as evidence of a stronger, more diversified, and more global platform, emphasizing record backlog, healthy client engagement, and broad-based contribution from all businesses. He highlighted continued strength in large-cap strategic M&A, gradual improvement in sponsor and middle-market activity, and growing opportunity in digital infrastructure financing and other non-M&A areas. His tone was confident but measured, repeatedly noting that while the market backdrop is complex, the underlying investment banking environment remains constructive.
Tim LaLonde emphasized the hard numbers behind the quarter: GAAP net revenues of $1.2 billion, GAAP EPS of $3.93, adjusted net revenues nearly $1.2 billion, and adjusted EPS of $4.28. He pointed to margin improvement, with the adjusted compensation ratio at 63% and the adjusted non-comp ratio at 14.1%, and said the year-to-date non-comp ratio was 13.7%, helped by stronger revenue and lower relative cost leverage. He also noted $2.8 billion of cash and investment securities, $189 million returned to shareholders in the quarter, over $1 billion returned year to date, and 43.5 million adjusted diluted shares, down nearly 1.2 million year over year.
Analysts focused on whether large-cap M&A can keep growing, and management said it is difficult to call cycles but that record backlogs, healthy replenishment, and strong client engagement support continued strength. They also pushed on SMD ramp, with Tim saying new hires typically produce little in a stub year, reach roughly 50% to two-thirds in the first full year, and become fully ramped by the second full year. Questions on non-comp expenses and seasonality drew a response that non-comp costs are trending better than last year and that fourth-quarter timing should not be predicted because backlog realization can shift. Management also said the Broadcom and Nexus data center financings show momentum in digital infrastructure, and that they do not expect a major M&A deal for the firm itself, preferring to hire people one by one rather than pursue a large transaction.
The call suggested Evercore is gaining share across multiple businesses, with management citing record backlogs, broad-based activity, and strength in both M&A and non-M&A offerings. The firm also appears to be benefiting from years of investment in sponsor coverage, middle-market coverage, and financing capabilities, while still maintaining strong productivity and capital returns.
Management acknowledged that market conditions remain complex, with interest-rate uncertainty, geopolitical tensions, and AI-related shifts still part of the backdrop. Sponsor and middle-market activity are improving but remain below historical levels, ECM activity may slow going into the fourth quarter, and the company said timing of backlog conversion can be lumpy. There is also execution risk around ramping more than 50 SMDs and continuing to lower non-comp growth while investing for future growth.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.4%
- Shares Outstanding
- 37.98M
- Float Shares
- 36.99M
of shares held by institutions
737 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for EVR, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Thomas Roland TillisSenate · NC | Sell | Feb 13, 15 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 3.84M | ▼ 62.04K |
| Blackrock, Inc. | 3.73M | ▲ 12.96K |
| Vanguard Portfolio Management LLC | 2.10M | ▲ 143.28K |
| Aqr Capital Management LLC | 1.71M | ▲ 394.13K |
| Vanguard Capital Management LLC | 1.65M | ▼ 25.64K |
| State Street Corp | 1.22M | ▲ 16.01K |
| Fmr LLC | 1.16M | ▲ 23.97K |
| Geode Capital Management, LLC | 1.09M | ▼ 9.42K |
| Invesco Ltd. | 741.35K | ▼ 861.32K |
| Morgan Stanley | 728.05K | ▼ 74.97K |
| Dimensional Fund Advisors LP | 676.62K | ▲ 120.20K |
| Millennium Management LLC | 637.46K | ▲ 568.31K |
Held by 645 ETFs
Biggest fund positions in EVR by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 11, 26 | LaLonde Timothy Gilbert | sell | 7,808 |
| Jun 10, 26 | Williamson Sarah K | other | 727 |
| Jun 10, 26 | WHEELER WILLIAM J | other | 364 |
| Jun 10, 26 | VARNEY CHRISTINE A | other | 727 |
| Jun 10, 26 | Robertson Sir Simon | other | 364 |
| Jun 10, 26 | OVERLOCK WILARD J JR | other | 727 |
| Jun 10, 26 | MILLARD ROBERT B | other | 815 |
| Jun 10, 26 | Harris Gail Block | other | 364 |
| Jun 10, 26 | FUTTER ELLEN V | other | 364 |
| Jun 10, 26 | Carlton Pamela G | other | 364 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EVR coverage
Recent articles, reports, and earnings notes.

Jefferies just proved the investment-banking rebound is real, and the stock still got punished
Jefferies just posted a very loud signal that the dealmaking rebound is real: investment-banking revenue surged 57% to a quarterly record. The stock got hit anyway, and that looks more like expectations getting reset after a huge run than the core franchise breaking.

Galaxy Digital is being re-rated as AI infrastructure, and that changes the whole stock
Galaxy Digital is starting to trade like an AI infrastructure owner, not just a levered crypto proxy. The reason is simple: Helios is now a financed, powered, revenue-producing campus, and that changes what the market is willing to pay for GLXY.

Lincoln International IPO Preview: Private Markets, Big Lockup
Lincoln International, Inc. (NYSE: LCLN) is expected to list on 2026-05-20 at a price range of $20.00 per share. The offering includes 21,049,988 shares and implies a market cap of $420,999,760. Watch whether investors focus on the firm’s 35% revenue growth and private-capital-market exposure, or on the controlled-company structure and future share supply.
Want a deeper read on EVR?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Teva to Present at the 9th Annual Evercore Healthcare Conference, the Piper Sandler 38th Annual Healthcare Conference and Citi's 2026 Global Healthcare Conference
globenewswire.com · Nov 20
AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare Conference
businesswire.com · Nov 20
IRulya Therapeutics to Participate in the 9th Annual Evercore Healthcare Conference
globenewswire.com · Nov 19
Butterfly Network to Present at 9th Annual Evercore Healthcare Conference on December 1, 2026
businesswire.com · Nov 17
Evercore: 3 Key Takeaways for Long-Term Investors
fool.com · Nov 17
Here's Why Evercore (EVR) is a Strong Growth Stock
zacks.com · Nov 10
Do Options Traders Know Something About Evercore Stock We Don't?
zacks.com · Nov 10
Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference
prnewswire.com · Nov 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.